Skip to content

13F-HR filed by Yiheng Capital Management, L.P.

Yiheng Capital Management, L.P. filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 27 holding rows worth $678,108,827.

Accession
0001420506-25-003340
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 27 entries on the cover page, a total value of $678,108,827 stated on the cover page (in dollars after the unit check, H1), rows summing to $678,108,827 with VALUE read as dollars as filed, 13F file number 028-17375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASTERA LABS INC COM04626A103COM1,427,500$279,504,500dollars as filedput
NOAH HLDGS LTD65487X102SPON ADS CL A6,717,351$77,854,098dollars as filed
JD.COM INC SPON ADS CL A47215P106ADR1,814,600$63,474,708dollars as filedcall
BILIBILI INC SPONS ADS REP Z090040106ADR1,418,564$39,847,463dollars as filed
NEW ORIENTAL ED & TECHNOLOGY SPON ADR647581206ADR521,901$27,697,286dollars as filed
JD.COM INC SPON ADS CL A47215P106ADR787,413$27,543,707dollars as filed
VIASAT INC92552V100COM735,500$21,550,150dollars as filedput
H WORLD GROUP LTD SPONSORED ADS44332N106ADR457,032$17,874,522dollars as filed
INVENTIVA SA46124U107ADS2,644,926$15,314,122dollars as filed
ATRENEW INC00138L108SPONSORED ADS3,163,117$14,550,338dollars as filed
BILIBILI INC SPONS ADS REP Z090040106ADR400,000$11,236,000dollars as filedcall
ACM RESH INC COM CL A00108J109Stock280,201$10,964,265dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM500,261$10,795,632dollars as filed
AKERO THERAPEUTICS INC00973Y108COM191,076$9,072,288dollars as filed
KYMERA THERAPEUTICS INC501575104COM122,605$6,939,443dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock469,981$6,824,124dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM225,758$6,790,801dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS656,309$6,563,090dollars as filed
SILVACO GROUP INC82728C102COMMON STOCK1,096,282$5,930,886dollars as filed
PONY AI INC732908108SPONSORED ADS200,300$4,504,747dollars as filed
CELLEBRITE DI LTD ORDINARY SHARESM2197Q107Stock231,031$4,281,004dollars as filed
TAL ED GROUP SPONSORED ADS874080104ADR309,240$3,463,488dollars as filed
Agora Inc-Adr00851L103COM533,547$2,038,150dollars as filed
BEAM THERAPEUTICS INC07373V105COM69,058$1,676,038dollars as filed
YATSEN HLDG LTD985194208CMN96,328$872,732dollars as filed
GENERATION BIO CO37148K209COM NEW105,524$645,807dollars as filed
TUNIU CORP89977P106SPONSORED ADS314,437$299,438dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-25-003340this filing2025-11-14acceptance time not in the bulk data set